Caxton Associates (New York)’s VEON VEON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,819
Closed -$106K 636
2020
Q1
$106K Buy
2,819
+2,245
+391% +$123K 0.02% 383
2019
Q4
$36K Sell
574
-3,134
-85% -$193K ﹤0.01% 387
2019
Q3
$222K Sell
3,708
-105
-3% -$7.2K 0.04% 328
2019
Q2
$267K Buy
+3,813
New +$228K 0.03% 310
2018
Q2
Sell
-10,274
Closed -$678K 483
2018
Q1
$678K Buy
+10,274
New +$861K 0.03% 235
2014
Q3
Sell
-15,640
Closed -$3.28M 259
2014
Q2
$3.28M Buy
+15,640
New +$3.29M 0.17% 101
2013
Q4
Sell
-848
Closed -$249K 276
2013
Q3
$249K Buy
+848
New +$226K 0.01% 161

Other funds holding VEON

Caxton Associates (New York)'s VEON Position: Q2 2020 in Review

Caxton Associates (New York) sold out of VEON (VEON) in Q2 2020, closing a stake of 2,819 shares — an estimated $106K sold.

Caxton Associates (New York) first reported a position in VEON in Q3 2013 and held it in 7 quarters. The position peaked at $3.28M in Q2 2014. 117 funds tracked by Wall St. Rank hold VEON as of Q2 2020.

  • Caxton Associates (New York) reported no remaining VEON position as of Q2 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 2,819 VEON shares in Q2 2020, an estimated $106K.
  • Caxton Associates (New York) first reported a position in VEON in Q3 2013 and held it in 7 quarters.
  • Caxton Associates (New York)'s VEON position peaked at $3.28M in Q2 2014.
  • 117 funds tracked by Wall St. Rank held VEON as of Q2 2020.

Based on Caxton Associates (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.